Latest Strategy News

Mach7 Technologies reports a positive operating cash flow in Q2 FY26, securing its first customer for the new Flamingo Architecture product and advancing key strategic initiatives.

Nine Entertainment Co. is reshaping its media portfolio with the acquisition of QMS Media, the sale of its radio assets, and a regional TV affiliate deal, aiming to boost digital revenue to over 60% by FY27.

Amplia Therapeutics reports encouraging clinical progress for its pancreatic cancer drug narmafotinib, with a 35% confirmed response rate in the ACCENT trial and FDA support for dose optimisation. The company also uplisted to the US OTCQB market and secured a key patent extending protection to 2040.

RMA Global Limited has rebranded RateMyAgent to Renowned, integrating Curated Social to enhance its real estate marketing platform. The company’s strategic pivot in the US is paying off with record brokerage deals and strong revenue growth.

NeuroScientific Biopharmaceuticals has reported promising initial clinical responses from its StemSmart™ Special Access Program treating Fistulising Crohn’s Disease, while preparing for a pivotal Phase 2 trial in 2026.

Magnum Mining & Exploration has accelerated its rare earth elements (REE) exploration with new drilling programs in Brazil and the acquisition of the Wet Mountains REE Project in Colorado, backed by a $7 million capital raise.

Murray Cod Australia Ltd reported a robust 61% increase in sales volume and secured key certifications in Q2 FY26, while navigating operational challenges and expanding its distribution footprint.

Fleetwood Limited has appointed Andrea Pidcock as its new CEO, bringing a wealth of operational and commercial leadership experience to the industrial and construction services company. Her appointment signals a strategic push towards operational excellence and growth through modern construction methods.

Galilee Energy has secured the Zydeco Gas Project in Louisiana and raised $6.5 million to fast-track development, marking a pivotal shift towards becoming a mid-tier US gas producer.

WhiteHawk Limited reported steady Q4 revenue and advanced multiple government and academic contracts in the US and Australia, underpinning its growth in cybersecurity services.

TrivarX Limited has expanded its diagnostic portfolio by acquiring the Stabl-Im brain cancer imaging technology and reported strong clinical trial results validating its single-lead ECG algorithm for depression screening in US veterans.

Fluence Corporation reported robust revenue and EBITDA growth in FY 2025, driven by strong contributions from its Ivory Coast project and expanding Smart Product Solutions. Leadership changes aim to accelerate growth as the company eyes continued momentum in 2026.